JX Luxventure Group Inc.

JXG

JX Luxventure Group Inc. provides tourism services and supplying related products in the People's Republic of China. It operates through three segments: Technology, Tourism Service, and Cross-Border E-Commerce. The company offers airline tickets and tourism services, such as travel packages, partnerships, technology, procurement of luxury assets, package design and curation, and supply and distribution; and software solution for tourism cross-border operations management.

About the company

Country: ChinaPrice: $12.58Market Cap: $212.1M

Investment snapshot

29%positive consensus

Scored 1d ago

Positive

BUY / PASS

Neutral / negative

3 / 8

NEUTRAL / FAIL

Median fair value

$14.80

+17.6% vs price

Models with upside

4 / 17

Positive margin of safety

Strongest signal

7 of 10 pass — Marks, Sleep and Oshaughnessy object

Key risk

No clean pass — all 8 investors flag at least one growth criterion

Framework analysis

Verdict	Meaning
BUY	Positive purchase signal: the framework's buy requirements are met.
PASS	The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRAL	Neither a positive nor negative conclusion. It does not mean to hold an existing position.
FAIL	The company does not clear the framework's requirements.
Ranked	Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

Metric	Graham Defensive Value	Buffett Quality Compounder	Lynch GARP	Greenblatt Magic Formula	Piotroski F-Score	Dreman Contrarian Value	Munger Quality Focus	Pabrai Dhandho Framework	Akre Three-Legged Stool	Marks Risk-Aware Value	Ackman Activist Value	Templeton Global Bargain Hunter	Sleep Scale Economies Shared	Asness Systematic Factors	Neff Low-P/E Total Return	Schloss Asset-Value Discipline	O'Shaughnessy Systematic Factor Composite
Verdict	FAIL	FAIL	FAIL	FAIL · Rank #1031 (Top 33.3%)	NEUTRAL	FAIL	BUY	NEUTRAL	PASS	FAIL	PASS	PASS	PASS	FAIL	FAIL	FAIL	NEUTRAL
Score
Analysis	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…
Intrinsic Value (annual)				N/A	N/A	N/A			N/A	N/A		N/A	N/A	N/A	N/A	N/A	N/A
Margin of Safety	+6.3%	+22.2%	-696.0%	N/A	N/A	N/A	+63.3%	-85.5%	N/A	N/A	+89.2%	N/A	N/A	N/A	N/A	N/A	N/A
Financial Basis	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 Latest source filing: 2025-05-15 Score computed: 2026-11-14	Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-05-15 Score computed: 2026-11-14

Where It Passes

Cash Flow70% pass✓ 9✗ 3▾
7 of 10 pass — Marks, Sleep and Oshaughnessy object
Free Cash Flow Proxy$3.1M
✓BuffettPositive and growing
FCF Positive and Growing$7.3M
✓LynchPositive and growing
Operating Cash Flow$7.7M
✓PiotroskiCFO > 0
(CFO / Total Assets) vs ROACFO/Assets=25.97%, ROA=10.35%
✓PiotroskiCFO/Assets > ROA
Price / (CFO / Shares)3.7x
✓Dreman< 8x
P/E or FCF YieldP/E=14.6x, FCF Yield=3.4%
✓PabraiP/E < 15 or FCF Yield > 10%
FCF Positive4/10 years FCF positive
✗MarksPositive FCF in majority of recent years
(OCF - CapEx) / Market Cap25.9%
✓Ackman>= 4%
Price / FCF per Share3.9x
✓Ackman<= 25
Positive Operating Cash Flow frequency4/12 years positive
✗SleepPositive OCF in >= 70% of available years
Operating Cash Flow - Capital Expenditures$7.3M
✓Neff> $0 (app proxy for a strong fundamental case)
(Operating cash flow - capex) / market capitalization+3.45%; #1940/4519 (top 42.9%)
✗OshaughnessyTop 10% of eligible cross-section
Debt & Leverage67% pass✓ 11✗ 4▾
8 of 12 pass — Graham, Lynch, Dreman +1 more object
LT Debt vs Net Current Assets
✗GrahamLT Debt <= Net Current Assets
Debt/Equity & Interest CoverageD/E: 0.08, IC: 275.8x
✓BuffettD/E < 0.5 AND Interest Coverage > 5x
Total Debt / Equity0.08
✓Lynch< 0.33
Cash - Long-term Debt
✗LynchPositive preferred
LT Debt / Total Assets Change0.00% -> 0.00%
✓PiotroskiDecreased YoY
Current Assets / Current Liabilities1.32
✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
Total Debt / Shareholders' Equity0.08
✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
Debt Levels0.08
✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
Interest Coverage & Debt/EBITDAIC=275.8x, D/EBITDA=0.4x
✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
Total Debt / Shareholders Equity0.08
✓Ackman<= 1.0
Negative debt-to-equity (higher means less debt)-0.0787; #1179/4210 (top 28.0%)
✓AsnessTop 30% of eligible cross-section
Valuation models67% pass✓ 4✗ 2▾
Models split on JXG at $12.58 — fair values range $1.58–$116.57
Graham fair value$13.42
✓Graham+6.3% margin vs $12.58
Buffett fair value$16.17
✓Buffett+22.2% margin vs $12.58
Lynch fair value$1.58
✗Lynch-696.0% margin vs $12.58
Munger fair value$34.29
✓Munger+63.3% margin vs $12.58
Pabrai fair value$6.78
✗Pabrai-85.5% margin vs $12.58
Ackman fair value$116.57
✓Ackman+89.2% margin vs $12.58

Where It Falls Short

Growth0% pass✓ 3✗ 10▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Basic earnings-growth PEG (dividends excluded)P/E 14.6x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR
✗Lynch15-30% (Fast Grower); > 0% to pass
Inventory Growth vs Revenue GrowthN/A (no inventory)
✓LynchInventory growth < Revenue growth
EPS Growth Direction
✗DremanPositive over recent years
EPS CAGR1.8% CAGR over 9 years
✗Dreman> 5% annualized
Positive Net Income Frequency3/12 years positive
✗MarksPositive net income in >= 7 of last 10 years
3yr Median Revenue Growth47.8%
✓Ackman>= 5%
Positive EPS Growth Frequency2/5 years with positive EPS growth
✗AckmanPositive EPS growth in >= 3 of last 5 years
5-Year EPS CAGR
✗Templeton> 0% (5-year EPS CAGR)
Revenue growth vs. gross and operating margin trendgross margin 1.8% -> 16.8%, operating margin -69.3% -> 7.7%
✗SleepRevenue rising; gross margin flat or falling; operating margin holding
5-year Revenue CAGR24.8%
✓SleepCAGR > 7%
3-5 Year Diluted EPS CAGR
✗Neff7%-20% annualized
Profitability6% pass✓ 8✗ 27▾
15 of 16 flag JXG's profitability — Graham, Buffett, Lynch +12 more
Positive EPS (10 years)3/13 years positive
✗GrahamPositive EPS every year for 10 years
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Net Income Positive (10+ years)3/13 years positive
✗BuffettPositive every year for 10+ years
ROE (up to 5-year arithmetic mean)-138.5%
✗Buffett> 15% arithmetic mean (app rule)
Operating Margin (10-yr trend)7.7% (latest)
✓BuffettStable or rising over 10 years
Free Cash Flow Proxy$3.1M
✓BuffettPositive and growing
Earnings Variance (10-yr CoV)
✗BuffettCoV < 0.3
Retained Earnings Effectiveness
✗Buffett$1 retained -> > $1 market value created
Basic earnings-growth PEG (dividends excluded)P/E 14.6x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR
✗Lynch15-30% (Fast Grower); > 0% to pass
ROE14.7%
✗Lynch> 15%
EBIT / Enterprise Value1.8%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=1.8%, ROC=101.4%
✗GreenblattBoth EY > 10% and ROC > 25%
Net Income / Total Assets10.35%
✓PiotroskiROA > 0
ROA Change YoY13.89% -> 10.35% (delta: -3.53%)
✗PiotroskiCurrent ROA > Prior ROA
(CFO / Total Assets) vs ROACFO/Assets=25.97%, ROA=10.35%
✓PiotroskiCFO/Assets > ROA
Gross Margin Change YoY17.1% -> 16.8%
✗PiotroskiImproved YoY
Pre-Tax Income / Revenue7.7%
✗Dreman>= 8%
Net Income / Shareholders' Equity14.7%
✓Dreman> 12%
Margin of SafetyP/E=14.6x, P/B=1.4x
✓PabraiP/B < 1.5 or P/E < 15
Return on Equity-187.2% (3-yr avg)
✗AkreROE > 20% (3-year avg)
Discount to Intrinsic ValueN/A (negative normalized EPS)
✗Marks>= 20% below intrinsic value
Positive Net Income Frequency3/12 years positive
✗MarksPositive net income in >= 7 of last 10 years
Operating Income / Revenue7.7%
✗Ackman>= 15%
Net Income / Shareholders Equity14.7%
✗Ackman>= 15%
5-Year EPS CAGR
✗Templeton> 0% (5-year EPS CAGR)
Operating Margin Trend-69.3% (2022) -> 7.7% (2024)
✓TempletonNon-negative operating-margin trend over 3 years
Revenue growth vs. gross and operating margin trendgross margin 1.8% -> 16.8%, operating margin -69.3% -> 7.7%
✗SleepRevenue rising; gross margin flat or falling; operating margin holding
Net income / market capitalization+1.45%; #2862/6340 (top 45.1%)
✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Gross profit / total assets+28.13%; #1539/3702 (top 41.6%)
✗AsnessTop 30% of eligible cross-section
Net income / positive book equity+14.71%; #1188/5226 (top 22.7%)
✓AsnessTop 30% of eligible cross-section
Negative 5-year standard deviation of ROA-1.7728; #5431/5884 (top 92.3%)
✗AsnessTop 30% of eligible cross-section
3-5 Year Diluted EPS CAGR
✗Neff7%-20% annualized
Positive Diluted-EPS Years3/10 years positive
✗Schloss>= 70% positive over 5-10 observed years (app rule)
Efficiency13% pass✓ 3✗ 8▾
7 of 8 flag JXG's efficiency — Graham, Buffett, Piotroski +4 more
Current Ratio1.32
✗Graham>= 2.0
ROIC (3-5 yr avg)-182.8%
✗Buffett> 10%
ROIC - WACC-192.8%
✗BuffettPositive (WACC = 10%)
EBIT / (NWC + Net Fixed Assets)101.4%
✓Greenblatt> 25%
Current Ratio Change YoY2.88 -> 1.32
✗PiotroskiIncreased YoY
Revenue / Total Assets Change YoY1.45x -> 1.68x
✓PiotroskiImproved YoY
Current Assets / Current Liabilities1.32
✗Dreman> 1.5
Return on Invested Capital13.4%
✗Munger> 15%
ROIC (high and growing)FY2022: ROIC=-326.2%; FY2023: ROIC=14.8%; FY2024: ROIC=13.4%
✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
Reinvestment Rate x ROIC13.4% (RR=100% x ROIC=13.4%)
✓AkreReinvestment Rate * ROIC > 10%
ROIC (5-year)2/5 years above 12% (latest 13.4%)
✗SleepROIC > 12% in a majority of years
Valuation23% pass✓ 9✗ 19▾
10 of 13 flag JXG's valuation — Graham, Lynch, Greenblatt +7 more
Price / Book Value per Share1.4x
✗Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
Price / 3-yr avg EPS
✗Graham<= 15x
Price-to-Book Ratio1.4x
✓Graham<= 1.5x
P/E x P/B
✗Graham<= 22.5
Basic earnings-growth PEG (dividends excluded)P/E 14.6x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
EBIT / Enterprise Value1.8%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=1.8%, ROC=101.4%
✗GreenblattBoth EY > 10% and ROC > 25%
Price / EPS14.6x
✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
Price / (CFO / Shares)3.7x
✓Dreman< 8x
Valuation ReasonablenessP/E=14.6x, OE Yield=10.5%
✓MungerP/E < 25 or Owner Earnings Yield > 5%
P/E or FCF YieldP/E=14.6x, FCF Yield=3.4%
✓PabraiP/E < 15 or FCF Yield > 10%
P/B or P/E vs. Historical AverageP/E=14.6x, P/B=1.4x
✓MarksP/E < 15 or P/B < 2.0
Discount to Intrinsic ValueN/A (negative normalized EPS)
✗Marks>= 20% below intrinsic value
Price / FCF per Share3.9x
✓Ackman<= 25
Price vs. Trailing Low337% of trailing low ($3.73)
✗Templeton<= 120% of trailing low (certified split-adjusted live window)
Net income / market capitalization+1.45%; #2862/6340 (top 45.1%)
✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Positive book equity / market capitalization+0.0986; #4755/6449 (top 73.7%)
✗AsnessTop 30% of eligible cross-section
Price / Diluted EPS14.6x
✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
(EPS CAGR % + Dividend Yield %) / P/E
✗Neff> 0.7 (Neff's published traditional edge)
Price / Tangible Book Value per Share5.69x
✗SchlossP/TBV <= 1.00x (app cutoff)
Book Value per Share Change-55.7%
✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
Revenue / market capitalization+0.2350; #3614/5247 (top 68.9%)
✗OshaughnessyTop 10% of eligible cross-section
(Operating cash flow - capex) / market capitalization+3.45%; #1940/4519 (top 42.9%)
✗OshaughnessyTop 10% of eligible cross-section
Trailing six-month price return through the evaluation date+218.48%; #136/6202 (top 2.2%)
✓OshaughnessyTop 10% of eligible cross-section
Verdicts36% pass✓ 5✗ 9▾
Split decision: 8 FAIL · 4 PASS · 3 NEUTRAL · 1 BUY
Overall verdict
✗GrahamFAIL (1/9)✗BuffettFAIL (3/9)✗LynchFAIL (3/7)✗GreenblattRank #1031•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (3/11)✓MungerBUY (3/4)•PabraiNEUTRAL (2/3)✓AkrePASS (3/6)✗MarksFAIL (2/5)✓AckmanPASS (5/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1099/2370 (Top 46.4%))✗NeffFAIL (3/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked)

Business & financials

Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.

Company Profile

Industry: Wholesale

SIC Sector: Durable Goods Wholesale

Size: Micro Cap($212.1M)

Revenue: $49.8M+56.5% YoY

Net Income: $3.1M+1.0% YoY

Financial Snapshot

Operating Margin7.7%

Return on Equity14.7%

Debt / Equity0.08

Current Ratio1.32

EPS (Diluted)$0.86+79.2% 1y

Shares Retired62.9% / −33.6% 2y

Similar Companies

MCKMCKESSON CORP

$127.3B

GWWW.W. GRAINGER, INC.

$69.7B

CAHCARDINAL HEALTH INC

$65.0B

SYYSYSCO CORP

$38.0B

Shareholder Return

Fiscal 2024

Retired 62.9% of shares last year, 33.6% issued over two.

Buybacks: —
Dividends: —

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY24

79.2% = 1.0% + 77.4%

Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

Metric	FY 2024 Sources 20-F · 2025-05-15	FY 2023 Sources 20-F · 2024-05-15	FY 2022 Sources 20-F/A · 2023-05-15	FY 2021 Sources 20-F · 2022-05-13	FY 2020 Sources 20-F · 2021-05-17
Market Cap	$212.1Mcurrent	$114.6Mest.	$229.5Mest.	$1.6Best.	$2.0Best.
Revenue	$49.8M↑57%	$31.8M↓60%	$79.9M↑48%	$54.0M↑3947%	$1.3M
Operating Income	$3.8M↑26%	$3.0M↑106%	-$55.4M↓654%	-$7.3M↓638%	-$995.3K
Net Income	$3.1M↑1%	$3.0M↑104%	-$73.5M↓97%	-$37.2M↓557%	-$5.7M
EPS (Diluted)	$0.86↑79%	$0.48↑101%	$-43.70↓431%	$-8.23↓294%	$-2.09
Gross Margin	16.8%↓2%	17.1%↑835%	1.8%↑17%	1.6%↓87%	12.5%
Operating Margin	7.7%↓20%	9.6%↑114%	-69.3%↓410%	-13.6%↑82%	-74.5%
ROE	14.7%↓27%	20.1%↑103%	-596.2%↓395%	-120.5%↓1060%	-10.4%
Total Debt	$1.6M↑51%	$1.1M	$1.1M↓8%	$1.2M↑3%	$1.1M
Shareholders' Equity	$20.9M↑38%	$15.2M↑23%	$12.3M↓60%	$30.9M↓43%	$54.5M
Current Ratio	1.32↓54%	2.88↑75%	1.65↓51%	3.35↓15%	3.96
Debt / Equity	0.08↑10%	0.07↓19%	0.09↑131%	0.04↑82%	0.02
Operating Cash Flow	$7.7M↑271%	-$4.5M↑9%	-$5.0M↑36%	-$7.8M↓19%	-$6.5M
Free Cash Flow	$7.3M↑262%	-$4.5M↑9%	-$5.0M↑55%	-$11.1M↓70%	-$6.5M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Wholesale

JXG vs Peers — Financial Grading

Revenue$49.8MBottom 25%

Net Income$3.1MBottom 25%

ROE14.7%Median

D/E0.08Median

Op. Margin7.7%Median

Curr. Ratio1.32Median

Company	Market Cap	Price	Revenue	Net Income	ROE	D/E	Op. Margin	Curr. Ratio	Graham	Buffett	Lynch	Greenblatt	Piotroski	Dreman
MCKESSON CORPMCK	$127.3B	$1102.81	$403.4B	$4.8B	-219.2%	-3.00	1.5%	0.85	2/9	5/9	4/7	0/3	F-Score 6	1/11
W.W. GRAINGER, INC.GWW	$69.7B	$1489.30	$17.9B	$1.7B	45.7%	0.67	13.9%	2.83	4/9	6/9	4/7	1/3	F-Score 6	5/11
CARDINAL HEALTH INCCAH	$65.0B	$281.10	$254.2B	$1.7B	-59.5%	-3.08	1.0%	0.88	2/9	3/9	3/7	0/3	F-Score 8	1/11
SYSCO CORPSYY	$38.0B	$77.10	$81.4B	$1.8B	99.9%	—	3.8%	1.21	3/9	5/9	5/7	1/3	F-Score 4	2/11
RELIANCE, INC.RS	$21.8B	$427.33	$14.3B	$739.4M	10.3%	0.20	7.1%	4.88	4/9	7/9	3/7	0/3	F-Score 5	5/11
WATSCO INCWSO	$12.8B	$308.46	$7.2B	$497.0M	17.9%	0.17	10.0%	4.12	5/9	7/9	4/7	1/3	F-Score 6	8/11
APPLIED INDUSTRIAL TECHNOLOGIES INCAIT	$10.9B	$297.60	$4.6B	$393.0M	21.3%	0.31	10.9%	3.32	6/9	5/9	4/7	1/3	F-Score 5	7/11
POOL CORPPOOL	$7.7B	$216.20	$5.3B	$406.4M	34.3%	1.01	11.0%	2.24	3/9	6/9	4/7	1/3	F-Score 5	6/11